Jul. 15 at 5:50 PM
US FDA Reviewers Highlight Safety Concerns With GSK’s Investigational Cancer Drug: Retail’s On The Fence
$GSK $DFAX $FDWM
https://stocktwits.com/news/equity/markets/us-fda-reviewers-highlight-safety-concerns-with-gsk-investigational-cancer-drug/ch8QfPRR5FC